FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Unichem Pharmaceuticals Bisoprolol Fumarate tablets Recall

Bisoprolol Fumarate tablets, 5 mg, 30-count bottles, Rx only, Manufactured by: UNICHE…

Unichem Pharmaceuticals Usa Inc · Hasbrouck Heights, NJ

Risk level
Class II
Reported by FDA
Oct 25, 2017
Recall ID
D-0010-2018
Check your lot numberHow we source this data

Summary

Unichem Pharmaceuticals recalled Bisoprolol Fumarate tablets starting Oct 2, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0010-2018 on Oct 25, 2017. Reason: Failed Impurities/Degradation Specifications: Out of Specification for an unknown impurity was observed during the 18 month stability testing. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: Out of Specification for an unknown impurity was observed during the 18 month stability testing.

Product description

Bisoprolol Fumarate tablets, 5 mg, 30-count bottles, Rx only, Manufactured by: UNICHEM LABORATORIES, LTD. Pilerne Ind. Estate, Pilerne, Bardez, Goa, 403 511, India, Marketed by: UNICHEM PHARMACEUTICALS, (USA), INC. Hasbrouck Heights, NJ 07604, NDC 29300-126-13.

Lot numbers, UPCs & expiration codes

Lot #: GBOL16001, GBOL16002, Exp 12/31/2017; GBOL16015, Exp 03/31/2018.

Where it was sold

Product was distributed nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0010-2018
Classification
Class II
Status
Terminated
Recall initiated
Oct 2, 2017
FDA report date
Oct 25, 2017
Quantity
96,876 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Unichem Pharmaceuticals Usa Inc

Original FDA data

Every field from FDA enforcement report D-0010-2018, exactly as published.

Show all FDA fields
City
Hasbrouck Heights
State
NJ
Status
Terminated
Country
United States
Event ID
78218
Address
777 Terrace Ave
Address (line 2)
Suite 102
Code information
Lot #: GBOL16001, GBOL16002, Exp 12/31/2017; GBOL16015, Exp 03/31/2018.
Postal code
07604-3102
Report date
Oct 25, 2017
Product type
Drugs
Recall number
D-0010-2018
Classification
Class II
Recalling firm
Unichem Pharmaceuticals Usa Inc
Product quantity
96,876 bottles
Termination date
Sep 13, 2018
Reason for recall
Failed Impurities/Degradation Specifications: Out of Specification for an unknown impurity was observed during the 18 month stability testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Bisoprolol Fumarate tablets, 5 mg, 30-count bottles, Rx only, Manufactured by: UNICHEM LABORATORIES, LTD. Pilerne Ind. Estate, Pilerne, Bardez, Goa, 403 511, India, Marketed by: UNICHEM PHARMACEUTICALS, (USA), INC. Hasbrouck Heights, NJ 07604, NDC 29300-126-13.
Distribution pattern
Product was distributed nationwide
Recall initiation date
Oct 2, 2017
Initial firm notification
Letter
Center classification date
Oct 18, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0010-2018, published Oct 25, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls